Overview
Mixed dementia (MD) refers to the coexistence of Alzheimer disease and vascular dementia, characterized by overlapping pathological features and clinical symptoms 1.Diagnosis
Assess oxidative DNA damage biomarkers, including urinary excretion of 8-oxo-2'-deoxyguanosine and cerebrospinal fluid levels of 8-oxoguanine 1.
Evaluate antioxidant levels such as ascorbic acid and retinol in plasma 1.
Consider neuropsychological testing to differentiate cognitive profiles 1.Management
Focus on managing vascular risk factors (e.g., hypertension, hyperlipidemia) to potentially slow disease progression 1.
Consider antioxidant supplementation based on identified deficiencies (e.g., vitamin C, vitamin A) 1.
Implement cognitive rehabilitation and supportive therapies to maintain function 1.Special Populations
No specific data provided for pregnancy, pediatrics, or unique considerations in the elderly or comorbid conditions 1.Key Recommendations
Measure oxidative DNA damage markers, such as urinary 8-oxo-2'-deoxyguanosine and CSF 8-oxoguanine, for early detection in MD patients (Evidence: Moderate) 1.
Monitor and manage systemic antioxidant levels, particularly ascorbic acid and retinol, in MD patients (Evidence: Moderate) 1.
Control vascular risk factors to mitigate disease progression in MD (Evidence: Expert opinion) 1.References
1 Gackowski D, Rozalski R, Siomek A, Dziaman T, Nicpon K, Klimarczyk M et al.. Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease/vascular dementia. Journal of the neurological sciences 2008. link